Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease Usama Abdel Azim Sharaf El Din, Mona Mansour Salem, Dina Ossama Abdulazim

Severe hyperchloremic metabolic acidosis with SGLT2 inhibitors in patients with urinary diversion Carolina Gomes, João Barbosa Barroso, Ana Isabel Oliveira, Sofia Guerreiro Cruz, Liliana Cunha, Ana Azevedo

Burden and challenges of heart failure in patients with chronic kidney disease. A call to action Gregorio Romero-González, Susana Ravassa, Omar González, Ignacio Lorenzo, Miguel Angel Rojas, Isabel García-Trigo, Nuria García-Fernández, Javier Lavilla, Paloma L. Martín, Begoña López, Arantxa González, Francisco J. Beaumont, Gorka San José, María U. Moreno, Noelia Ania, Elena Osacar, Pilar Amézqueta, Javier Díez